Evidence Inconclusive for Benefits of Kinesio Taping for Musculoskeletal Disorders
via HealthDayMONDAY, April 6, 2026 -- Kinesio taping (KT) for musculoskeletal disorders (MSDs) may reduce pain intensity in the immediate and short term, but the evidence is uncertain, according to a study published online March 31 in BMJ Evidence-Based Medicine.
Qingcong Mo, from the Southern Medical University in Guangzhou, China, and colleagues examined the effectiveness and clinical relevance of KT in MSDs in an overview of systematic reviews (SRs) and evidence mapping. The analyses included data from 128 SRs with 15,812 participants from 310 unique randomized controlled trials.
The researchers found that in meta-analyses, KT appeared to reduce pain intensity in the immediate and short term (Hedges' g, –0.69 and –0.57, respectively) and improve function/disability in the immediate term (Hedges' g, –0.54). The predefined minimal clinically important difference of 0.5 standard deviations may be achieved by these effect estimates (medium effect size), the researchers noted. Data indicated that little to no effect on pain intensity in the medium term, function/disability in the short and medium term, muscle strength, range of motion, and disease-specific symptoms at all follow-ups may be seen with KT. Across subgroups or conditions, there were variable effects of KT; an unclear impact on quality of life was seen. KT-related adverse events mainly included skin irritation and pruritus (number needed to harm, 173 and 356, respectively). Because of very low certainty, nonsignificant level, and unstable clinical relevance across most outcomes, all evidence was highly inconclusive.
"This overview of SRs and evidence mapping shows that current evidence is very uncertain regarding the clinical effects of KT on MSDs across all follow-ups," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-07 01:53
Read more
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara) Brain Cancer Imaging Candidate
- AAP Guidelines Address Parental Requests for Nonbeneficial Treatments
- For Teens, AI Dietary Recommendations Deviate From Dietitian Plans
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Xspray Pharma Re-Submits its FDA Application for Dasynoc
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions